<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Drugs used in the treatment of narcolepsy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Drugs used in the treatment of narcolepsy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Drugs used in the treatment of narcolepsy</div><div class="cntnt"><table cellspacing="0"><colgroup width="19%"></colgroup><colgroup span="3" width="27%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Dosage, usual (adult)</td> <td class="subtitle1">Common side effects</td> <td class="subtitle1">Serious side effects</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Excessive daytime sleepiness</td> </tr> <tr> <td class="indent1">Modafinil</td> <td>100 to 400 mg every morning <strong>or</strong> 200 mg twice per day</td> <td>Headache, nervousness, nausea, insomnia</td> <td>Severe rash</td> </tr> <tr> <td class="indent1">Armodafinil</td> <td>150 to 250 mg every morning <strong>or</strong> 125 mg (half of 250 mg tablet) twice per day</td> <td>Headache, nervousness, nausea, insomnia</td> <td>Severe rash</td> </tr> <tr> <td class="indent1">Solriamfetol</td> <td>75 to 150 mg every morning</td> <td>Headache, nausea, reduced appetite</td> <td>Cardiovascular effects</td> </tr> <tr> <td class="indent1">Pitolisant*</td> <td>8.9 to 35.6 mg once per day</td> <td>Headache, insomnia, nausea, anxiety</td> <td>Severe rash, QT prolongation</td> </tr> <tr> <td class="indent1">Methylphenidate</td> <td>10 to 30 mg twice per day <strong>or</strong> 20 mg extended release every morning with 10 to 20 mg immediate or extended release every afternoon<sup>¶</sup></td> <td>Reduced appetite, nausea, headache, insomnia</td> <td>Abuse potential, psychosis, mania, seizures, cardiovascular effects<sup>Δ</sup></td> </tr> <tr> <td class="indent1">Dextroamphetamine</td> <td>5 to 30 mg twice per day <strong>or</strong> 10 mg extended release every morning with 10 to 20 mg immediate or extended release every afternoon<sup>¶</sup></td> <td>Reduced appetite, nausea, headache, insomnia</td> <td>High abuse potential, psychosis, mania, seizures, cardiovascular effects<sup>Δ</sup></td> </tr> <tr> <td class="indent1">Amphetamine-dextroamphetamine</td> <td>10 to 30 mg twice per day <strong>or</strong> 20 mg extended release twice per day<sup>¶</sup></td> <td>Reduced appetite, nausea, headache, insomnia</td> <td>High abuse potential, psychosis, mania, seizures, cardiovascular effects<sup>Δ</sup></td> </tr> <tr> <td class="indent1">Amphetamine sulfate</td> <td>10 to 60 mg per day in two or three divided doses</td> <td>Reduced appetite, nausea, headache, insomnia</td> <td>High abuse potential, psychosis, mania, seizures, cardiovascular effects<sup>Δ</sup></td> </tr> <tr> <td class="indent1">Oxybates (gamma hydroxybutyrate)</td> <td>2.25 to 4.5 grams at bedtime <strong>and</strong> repeated 3 to 4 hours later<sup>◊</sup></td> <td>Morning sedation, nausea, dizziness, urinary incontinence, sleepwalking</td> <td>Abuse potential, confusion, severe sedation, coma<sup>§</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="4">Cataplexy<sup>¥</sup></td> </tr> <tr> <td class="indent1">Venlafaxine</td> <td>37.5 to 75 mg twice per day <strong>or</strong> 37.5 to 150 mg extended release every morning</td> <td>Transient nausea, headache, insomnia, increase in blood-pressure when given in higher doses</td> <td> </td> </tr> <tr> <td class="indent1">Fluoxetine</td> <td>20 to 80 mg every morning</td> <td>Nausea, dry mouth, insomnia</td> <td>QT prolongation</td> </tr> <tr> <td class="indent1">Clomipramine</td> <td>10 to 150 mg as a single dose every morning or in divided doses</td> <td>Dry mouth, constipation, sweating, dizziness, somnolence, weight gain, orthostatic hypotension</td> <td>Cardiotoxicity, seizures, dangerous in overdose<sup>‡</sup></td> </tr> <tr> <td class="indent1">Protriptyline</td> <td>5 to 60 mg as a single dose every morning or in divided doses</td> <td>Dry mouth, constipation, sweating, anxiety, disturbed nighttime sleep, orthostatic hypotension</td> <td>Cardiotoxicity, seizures, dangerous in overdose<sup>‡</sup></td> </tr> <tr> <td class="indent1">Pitolisant</td> <td>8.9 to 35.6 mg once per day</td> <td>Headache, insomnia, nausea, anxiety</td> <td>Severe rash, QT prolongation</td> </tr> <tr> <td class="indent1">Oxybates (gamma hydroxybutyrate)</td> <td>2.25 to 4.5 grams at bedtime <strong>and</strong> repeated 3 to 4 hours later<sup>◊</sup></td> <td>Morning sedation, nausea, dizziness, urinary incontinence, sleepwalking</td> <td>Abuse potential, confusion, severe sedation, coma<sup>§</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="4">Disrupted nighttime sleep<sup>†</sup></td> </tr> <tr> <td class="indent1">Zolpidem</td> <td>5 to 10 mg at bedtime</td> <td>Morning sedation, dizziness</td> <td> </td> </tr> <tr> <td class="indent1">Oxybates (gamma hydroxybutyrate)</td> <td>2.25 to 4.5 grams at bedtime <strong>and</strong> repeated 3 to 4 hours later<sup>◊</sup></td> <td>Morning sedation, nausea, dizziness, urinary incontinence, sleepwalking</td> <td>Abuse potential, confusion, severe sedation, coma<sup>§</sup></td> </tr> </tbody></table></div><div class="graphic_lgnd">Most of the medications listed in this table require gradual dose titration and administration at specific scheduled times to optimize patient response. For details, refer to the topic review and the Lexicomp individual drug monographs.</div><div class="graphic_footnotes"><p>* Also has anti-cataplexy effects.</p>
<p>¶ Although extended-release formulations are intended to be taken once daily, many patients with narcolepsy find that the clinical effect wears off in four to six hours, necessitating a second dose in the early afternoon.</p>
<p>Δ For additional information, refer to topic review of treatment of attention deficit hyperactivity disorder in adults or adolescents, section on adverse effects.</p>
<p>◊ Dosing provided is for immediate-release formulations (ie, sodium oxybate or oxybate salts).</p>
<p>§ Combined use with alcohol, sedatives, or hypnotics is specifically contraindicated in United States licensing information.</p>
<p>¥ Anti-cataplexy medications are also useful for problematic sleep paralysis or hypnagogic hallucinations.</p>
<p>‡ For additional information, refer to topic review of tricyclic antidepressants, section on adverse effects.</p>
† Some sleep disruption in narcolepsy may be caused by additional sleep disorders that require specific treatment (examples include obstructive sleep apnea or periodic limb movements of sleep).</div><div class="graphic_reference">Adapted from: Scammell TE. The Neurobiology, diagnosis, and treatment of Narcolepsy. Ann Neurol 2003; 53:154.</div><div id="graphicVersion">Graphic 73910 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
